These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1714675)

  • 1. Transurethral balloon dilatation of the prostatic urethra: effectiveness in highly selected patients with prostatism.
    Wasserman NF; Reddy PK; Zhang G; Kapoor DA; Berg P
    AJR Am J Roentgenol; 1991 Sep; 157(3):509-12. PubMed ID: 1714675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia.
    Djavan B; Fakhari M; Shariat S; Ghawidel K; Marberger M
    J Urol; 1999 Jan; 161(1):144-51. PubMed ID: 10037387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transurethral balloon dilatation of the prostate: initial results, indication and complication].
    Horii A; Kyo M; Yasumoto R; Harima M; Tanaka S; Sakakura T; Iritani Y; Kishimoto T; Maekawa M
    Hinyokika Kiyo; 1991 Nov; 37(11):1455-61. PubMed ID: 1722633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Balloon dilatation vs. prostatic transurethral resection in stages I-II prostatic adenoma].
    Recker F; Tscholl R
    Helv Chir Acta; 1993 Dec; 60(3):335-9. PubMed ID: 7509782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans.
    Wasserman NF; Reddy PK; Zhang G; Berg PA
    Radiology; 1990 Nov; 177(2):485-94. PubMed ID: 1699247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia.
    Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y
    J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Kahn SA; Alphonse P; Tewari A; Narayan P
    J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
    de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
    Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of demographic factors, urinary peak flow rates, and Boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia.
    Kaplan SA; Goluboff ET; Olsson CA; Deverka PA; Chmiel JJ
    Urology; 1995 Mar; 45(3):398-405. PubMed ID: 7533451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar plasmakinetic transurethral resection of prostate in 132 consecutive patients with large gland: three-year follow-up results.
    Zhu G; Xie C; Wang X; Tang X
    Urology; 2012 Feb; 79(2):397-402. PubMed ID: 22035765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of benign prostatic hypertrophy using balloon dilation].
    Nakamura K; Nakajima N; Hihara T; Baba S; Tazaki H
    Hinyokika Kiyo; 1991 Nov; 37(11):1463-5. PubMed ID: 1722634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
    Narayan P; Tewari A; Aboseif S; Evans C
    J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride following balloon dilatation of the prostate. A double-blind, placebo-controlled, multicenter study.
    Lukkarinen O; Lehtonen T; Talja M; Lundstedt S; Tiitinen J; Taari K
    Ann Chir Gynaecol; 1999; 88(4):299-303. PubMed ID: 10661828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy.
    Laguna MP; Kiemeney LA; Debruyne FM; de la Rosette JJ
    J Urol; 2002 Apr; 167(4):1727-30. PubMed ID: 11912397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.